Cipla : Annual Return 2022-23

FORM NO. MGT-7

[Pursuant to sub-Section(1) of section 92 of the Companies Act, 2013 and sub-rule (1) of rule 11of the Companies (Management and Administration) Rules, 2014]

Annual Return

(other than OPCs and Small Companies)

Form language

English

Hindi

Refer the instruction kit for filing the form.

I. REGISTRATION AND OTHER DETAILS

(i) * Corporate Identification Number (CIN) of the company	L24239MH1935PLC002380			Pre-fill
	Global Location Number (GLN) of the company
* Permanent Account Number (PAN) of the company	AAACC1450B
(ii)	(a) Name of the company		CIPLA LIMITED
	(b) Registered office address
	Cipla House, Peninsula Business Park Ganpatrao Kadam Marg,
	Lower Parel NA
	Mumbai
	Mumbai City
	Maharashtra
	400013
	(c) *e-mail ID of the company		[e-mail]
	(d) *Telephone number with STD code	2224826000
	(e) Website		www.cipla.com
(iii)		Date of Incorporation		17/08/1935
(iv)
	Type of the Company	Category of the Company		Sub-category of the Company
		Public Company	Company limited by shares		Indian Non-Government company
(v) Whether company is having share capital	Yes	No
(vi) *Whether shares listed on recognized Stock Exchange(s)	Yes	No

Page 1 of 18

(a) Details of stock exchanges where shares are listed

S. No.

Stock Exchange Name

Code

1

BSE Limited

1

2

National Stock Exchange of India Limited

1,024

Pre-fill

(b) CIN of the Registrar and Transfer Agent

L72400TG2017PLC117649

Name of the Registrar and Transfer Agent

KFIN TECHNOLOGIES LIMITED

Registered office address of the Registrar and Transfer Agents

Selenium, Tower B, Plot No- 31 & 32, Financial District, N

anakramguda, Serili ngampally NA

(DD/MM/YYYY)

(vii) *Financial year From date 01/04/2022

(DD/MM/YYYY) To date

31/03/2023

(viii) *Whether Annual general meeting (AGM) held

Yes

No

(a) If yes, date of AGM

(b) Due date of AGM

(c) Whether any extension for AGM granted

Yes

No

II. PRINCIPAL BUSINESS ACTIVITIES OF THE COMPANY

*Number of business activities 2

S.No

Main

Description of Main Activity group

Business

Description of Business Activity

% of turnover

Activity

Activity

of the

group code

Code

company

1

C

Manufacturing

C6

Chemical and chemical products,

72.05

pharmaceuticals, medicinal chemical and

b

t i l d t

2

G

Trade

G1

Wholesale Trading

19.98

1. PARTICULARS OF HOLDING, SUBSIDIARY AND ASSOCIATE COMPANIES (INCLUDING JOINT VENTURES)

*No. of Companies for which information is to be given 53		Pre-fill All
S.No	Name of the company		CIN / FCRN	Holding/ Subsidiary/Associate/	% of shares held
						Joint Venture
1	Jay Precision Pharmaceuticals		U33111MH2012PTC234037		Subsidiary	60

Page 2 of 18

2	Meditab Specialities Limited	U23240MH1996PLC104442	Subsidiary	100
3	Medispray Laboratories Private	U52311GA1992PTC002801	Subsidiary	100
4	Goldencross Pharma Limited	U24239MH2000PLC123766	Subsidiary	100
5	Sitec Labs Limited	U74999MH2000PLC129210	Subsidiary	100
6	Cipla Health Limited	U24100MH2015PLC267880	Subsidiary	100
7	Cipla Pharma and Life Sciences	U24239MH2008PLC381559	Subsidiary	100
8	Cipla Pharmaceuticals Limited	U24239MH2019PLC333266	Subsidiary	100
9	Cipla Digital Health Limited	U72900MH2022PLC377512	Subsidiary	100
10	Cipla Europe NV		Subsidiary	100
11	Cipla Holding B.V.		Subsidiary	100
12	Cipla (EU) Limited		Subsidiary	100
13	Cipla Algérie		Subsidiary	40
14	Cipla Australia Pty Limited		Subsidiary	100
15	Cipla Brasil Importadora E Dist		Subsidiary	100
16	Cipla (China) Pharmaceutical C		Subsidiary	100
17	Cipla (Jiangsu) Pharmaceutical		Subsidiary	93.1
18	Cipla Colombia SAS		Subsidiary	100
19	Cipla Malaysia Sdn. Bhd.		Subsidiary	100
20	Meditab Holdings Limited		Subsidiary	100
21	Cipla Maroc SA		Subsidiary	60
22	Cipla Philippines, Inc.		Subsidiary	100
23	Breathe Free Lanka (Private) Li		Subsidiary	100
24	Cipla Gulf FZ - LLC		Subsidiary	100
25	Saba Investment Limited		Subsidiary	51
26	Cipla Middle East Pharmaceuti		Subsidiary	51

Page 3 of 18

27	Cipla Medica Pharmaceutical a		Subsidiary	50.49
28	Cipla Medpro South Africa (Pty		Subsidiary	100
29	Cipla Dibcare (Pty) Limited		Subsidiary	100
30	Cipla-Medpro Distribution Cen		Subsidiary	100
31	Cipla Medpro Manufacturing (P		Subsidiary	100
32	Cipla-Medpro (Pty) Limited		Subsidiary	100
33	Cipla Select (Pty) Limited		Subsidiary	100
34	Medpro Pharmaceutica (Pty) L		Subsidiary	100
35	Mirren (Pty) Limited		Subsidiary	100
36	Cipla Medpro Botswana (Pty) L		Subsidiary	100
37	Cipla Kenya Limited		Subsidiary	100
38	Cipla Quality Chemical Industr		Subsidiary	100
39	InvaGen Pharmaceuticals Inc.		Subsidiary	100
40	Cipla Technologies LLC		Subsidiary	100
41	Cipla Therapeutics Inc		Subsidiary	100
42	Cipla USA Inc.		Subsidiary	100
43	Exelan Pharmaceuticals Inc.		Subsidiary	100
44	Madison Pharmaceuticals Inc.		Subsidiary	100
45	Aspergen Inc.		Subsidiary	60
46	Stempeutics Research Private L	U73100KA2006PTC038256	Associate	33.18
47	GoApptiv Private Limited	U74999MH2015PTC263070	Associate	22.02
48	AMP Energy Green Eleven Priv	U40106DL2020PTC373516	Associate	32.49
49	AMPSolar Power Systems Priva	U74996DL2019PTC345639	Associate	26
50	Clean Max Auriga Power LLP		Associate	33
51	Achira Labs Pvt Limited	U73100KA2009PTC051466	Associate	21.05

Page 4 of 18

52	Brandmed (Pty) Limited	Associate	30
53	Iconphygital Private Limited U72900MH2021PTC359833	Associate	22.02

IV. SHARE CAPITAL, DEBENTURES AND OTHER SECURITIES OF THE COMPANY

(i) *SHARE CAPITAL

(a) Equity share capital

Particulars

Authorised

Issued

Subscribed

Paid up capital

capital

capital

capital

Total number of equity shares

875,000,000

807,150,593

807,150,593

807,150,593

Total amount of equity shares (in

1,750,000,000

1,614,301,186

1,614,301,186

1,614,301,186

Rupees)

Number of classes

1

Class of Shares

Authorised

Issued

Subscribed

capital

Paid up capital

Equity shares

capital

capital

Number of equity shares

875,000,000

807,150,593

807,150,593

807,150,593

Nominal value per share (in rupees)

2

2

2

2

Total amount of equity shares (in rupees)

1,750,000,000

1,614,301,186

1,614,301,186

1,614,301,186

(b) Preference share capital

Particulars

Authorised

Issued

Subscribed

Paid-up capital

capital

capital

capital

Total number of preference shares

0

0

0

0

Total amount of preference shares

0

0

0

0

(in rupees)

Number of classes

0

Class of shares

Authorised

Issued

Subscribed

capital

capital

capital

Paid up capital

Number of preference shares

Nominal value per share (in rupees)

Total amount of preference shares (in rupees)

(c) Unclassified share capital

Particulars

Authorised Capital

Total amount of unclassified shares

0

(d) Break-up of paid-up share capital

Page 5 of 18